IL-17R-EGFR axis links wound healing to tumorigenesis in Lrig1+ stem cells.
Xing ChenGang CaiCaini LiuJunjie ZhaoChunfang GuLing WuThomas A HamiltonCun-Jin ZhangJennifer Susan KoLiang ZhuJun QinAllison VidimosShlomo KoyfmanBrian R GastmanKim B JensenXiaoxia LiPublished in: The Journal of experimental medicine (2018)
Lrig1 marks a distinct population of stem cells restricted to the upper pilosebaceous unit in normal epidermis. Here we report that IL-17A-mediated activation of EGFR plays a critical role in the expansion and migration of Lrig1+ stem cells and their progenies in response to wounding, thereby promoting wound healing and skin tumorigenesis. Lrig1-specific deletion of the IL-17R adaptor Act1 or EGFR in mice impairs wound healing and reduces tumor formation. Mechanistically, IL-17R recruits EGFR for IL-17A-mediated signaling in Lrig1+ stem cells. While TRAF4, enriched in Lrig1+ stem cells, tethers IL-17RA and EGFR, Act1 recruits c-Src for IL-17A-induced EGFR transactivation and downstream activation of ERK5, which promotes the expansion and migration of Lrig1+ stem cells. This study demonstrates that IL-17A activates the IL-17R-EGFR axis in Lrig1+ stem cells linking wound healing to tumorigenesis.